Ken Griffin Rvl Pharmaceuticals PLC Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.56 - $1.17 $10,472 - $21,879
-18,700 Reduced 62.33%
11,300 $6,000
Q1 2023

May 15, 2023
SELL
$1.02 - $1.39 $11,832 - $16,123
-11,600 Reduced 27.88%
30,000 $34,000
Q4 2022

Feb 14, 2023
BUY
$1.02 - $1.61 $1,938 - $3,059
1,900 Added 4.79%
41,600 $46,000
Q3 2022

Nov 14, 2022
BUY
$1.28 - $2.91 $34,048 - $77,406
26,600 Added 203.05%
39,700 $83,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email